Stock Markets February 12, 2026

OneMedNet Shares Jump After Company Posts Record $2.79M in 2025 Bookings

AI-driven healthcare data provider cites larger deals and move to subscription revenue as drivers of growth

By Priya Menon ONMD
OneMedNet Shares Jump After Company Posts Record $2.79M in 2025 Bookings
ONMD

OneMedNet Corp's stock rose 16% on Thursday after the company disclosed record bookings for 2025 totaling $2.79 million in contract value. Bookings were 4.1 times the prior fiscal year, and management highlighted expanding deal sizes, strong enterprise demand, and a deliberate shift from project work to recurring subscription agreements as key contributors.

Key Points

  • OneMedNet reported $2.79 million in contract value for 2025 data-delivery bookings, a 4.1X increase versus the prior fiscal year.
  • Management cited increasing deal sizes, strong enterprise demand, and progress toward recurring subscriptions as drivers of growth; the company plans a mix of bespoke data projects and subscription services for 2026.
  • The company is positioning premium recurring revenue solutions powered by Palantir Foundry to create a more predictable, higher-margin, and scalable revenue profile.

OneMedNet Corp (NASDAQ:ONMD) saw its shares climb 16% on Thursday following the release of its 2025 bookings figures. The company reported $2.79 million in contract value for data-delivery agreements booked for 2025.

Management said the 2025 bookings represent a substantial increase over the previous fiscal year, specifically exceeding last year by 4.1X. The company attributed the surge to three interrelated factors: larger deal sizes, heightened enterprise demand, and progress toward a recurring subscription model.

Executive commentary

"This year represents a strategic inflection point for OneMedNet," said Aaron Green, CEO & President of OneMedNet. "We are increasing bookings and deal size, and we are successfully transitioning from project-based engagements to recurring subscription partnerships. This shift enhances visibility, predictability, and long-term enterprise value."

Product and revenue mix heading into 2026

The company said it is approaching 2026 with a broader mix of offerings that combine one-off data projects and subscription services. The announced portfolio includes:

  • curated bespoke data sets tailored to specific client needs,
  • pre-curated specialty datasets,
  • Palantir Agentic Search for data discovery, and
  • subscription data licenses that provide near real-time streaming healthcare data feeds.

OneMedNet emphasized the role of its premium recurring revenue solutions powered by Palantir Foundry, noting that these subscription offerings are expected to support a more predictable, higher-margin, and scalable revenue profile as the business shifts toward a predominantly subscription-based model.

Market signal and corporate positioning

The company framed the recent bookings milestone as confirmation of momentum driven by enterprise demand and larger contracts. Management described the transition away from project-only engagements and toward subscription partnerships as central to improving revenue visibility and long-term enterprise value.


Note on information scope

The details provided here reflect the information OneMedNet disclosed regarding its 2025 bookings total, the comparative 4.1X increase, the product mix planned for 2026, and management commentary on the strategic shift to subscription revenue. Where the company highlighted expectations for the subscription solutions to create a more predictable and higher-margin revenue profile, that expectation was presented by the company as part of its strategic outlook.

Risks

  • The company is in the process of transitioning from project-based engagements to recurring subscription partnerships; the ultimate success of that transition will determine whether revenue becomes more predictable and higher-margin.
  • Future performance appears linked to continued enterprise demand and larger deal sizes; any weakening in enterprise demand could affect bookings growth.
  • Execution of the planned product and subscription mix into 2026 will be necessary to realize the stated expectations for a scalable subscription-based revenue profile.

More from Stock Markets

Chinese AI Stocks Rally as Investors Embrace Winners While U.S. Markets Worry Feb 21, 2026 Three Earnings Reports This Week Will Test the Durability of the AI Investment Theme Feb 21, 2026 Moscow Market Closes Flat as Select Large-Caps Offset Losses Feb 21, 2026 Honeywell Reconsiders Purchase of Johnson Matthey Catalyst Unit as Closing Obstacles Emerge Feb 21, 2026 Indigenous Occupation Halts Operations at Cargill’s Santarem Terminal Feb 21, 2026